Offner Technologies

What Offner Technologies does

Offner Technologies is a privately held Israeli invention and development company (1–10 employees, headquartered in Yehud-Monosson, Israel) building a medical device platform around Non-Linear Standing Wave Interferometry (NL-SWI), a proprietary acoustic measurement technique that uses harmless acoustic waves to achieve near-molecular precision independent of wave frequency. The company is concurrently developing three core devices on this single platform: a radiation-free diagnostic imager positioned to replace MRI, CT, and conventional ultrasound; a non-invasive glucose monitor that measures blood glucose through closed eyelids in under ten seconds with approximately 10 picosecond resolution; and a brain stroke detection device using low-frequency acoustic waves (~200 KHz) that penetrate the skull with sub-millimetre precision for ambulance, clinic, and bedside use.

The technology stack is built on physical principles in standing wave interferometry that the previous generation of the technology demonstrated with 26 patents, 170+ scientific citations, and working collaborations with Fortune 500 companies; the underlying ultrasonic phase measurement physics has also been independently validated at NASA Langley Research Center. The current implementation is a fully computer-controlled system developed with the assistance of artificial intelligence, with disclosed precision metrics of approximately 5 nanometer step control of wave penetration and roughly 10 picosecond transit-time resolution. The platform's differentiating safety profile — no radiation, no magnets, no contrast agents, no helium, no shielded rooms — supports portable, infrastructure-free operation across hospital, clinic, ambulance, field, and home settings.

The business model is invention-and-licensing rather than direct commercialization. Offner Technologies explicitly seeks a single strategic partner with clinical expertise, regulatory experience navigating FDA and CE approval pathways, manufacturing capability, and global distribution. The company will retain the invention function; the partner will implement. Pricing, revenue, and customer relationships are not yet established, and the company is in advanced development awaiting clinical validation and a commercialization partner. Addressable markets cited include the $30B+ global glucose monitoring market by 2030, a $50–65B diagnostic imaging industry under structural pressure from helium costs and radiation safety concerns, and approximately 15 million annual strokes globally.

Name

Offner Technologies

Legal name

Offner Technologies

Website

https://offnertechnology.com

Company type

Private

Founded year

2022

Operating status

Operating

Headcount range

1–10 employees

Short description

Offner Technologies is a privately held Israeli medical device inventor developing a radiation-free acoustic measurement platform (Non-Linear Standing Wave Interferometry) for diagnostic imaging, non-invasive glucose monitoring, and brain stroke detection, currently seeking a strategic partner for clinical validation and commercialization.

Ownership category

akta.pro rank

Product category

Medical Devices

NAICS

Electromedical and Electrotherapeutic Apparatus Manufacturing (334510), Navigational, Measuring, Electromedical, and Control Instruments Manufacturing (33451), Navigational, Measuring, Electromedical, and Control Instruments Manufacturing (3345)

SIC

Surgical & Medical Instruments & Apparatus (3841), Electromedical & Electrotherapeutic Apparatus (3845)

akta.pro primary industry

Interventional Radiology & Image-Guided Therapy Systems (HLAHABAG)

akta.pro secondary industry

Remote Diagnostics & Home Testing Devices (Connected POC/At-Home Diagnostic Readers) (HLAHACAL)

Keywords

• Non-invasive medical devices
• Acoustic diagnostics
• Radiation-free imaging
• Glucose monitoring
• Stroke detection

Headquarters

HQ city

Yehud-Monosson

HQ country

Israel

HQ region

Middle East

Offices1 record

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Technology or R&D, Personnel, Operations, Marketing or Sales, Others

Revenue model

1. Medical Device Sales: Revenue will be generated through sale of medical diagnostic devices across three product lines: radiation-free diagnostic imaging, non-invasive glucose measurement, and brain stroke detection. Currently in advanced development seeking strategic partner for clinical validation and commercialization.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels1 record

Core offering

Offner Technologies develops a medical device platform based on proprietary Non-Linear Standing Wave Interferometry (NL-SWI) that uses harmless acoustic waves to achieve near-molecular precision independent of wave frequency. The company is currently developing three distinct medical devices — a radiation-free diagnostic imager, a non-invasive glucose monitor that measures through closed eyelids in under ten seconds, and a brain stroke detection device using low-frequency acoustic waves that penetrate the skull. The company is in advanced development and is actively seeking a strategic partner for clinical validation, regulatory approval (FDA/CE), manufacturing, and global distribution.

Product overview

Offner Technologies is developing a medical device platform based on Non-Linear Standing Wave Interferometry (NL-SWI) — a technology that uses harmless acoustic waves to achieve near-molecular precision, independent of wave frequency. The platform consists of three core medical devices: (1) the Radiation-Free Diagnostic Imager, designed to replace MRI, CT, and ultrasound with a single portable device; (2) the Non-Invasive Glucose Monitor, which measures blood glucose through closed eyelids in under ten seconds without needles; and (3) the Brain Stroke Detection Device, which uses low-frequency acoustic waves to penetrate the skull and provide full brain imaging at any location. All three devices share the same underlying NL-SWI acoustic measurement platform while targeting different clinical applications in diagnostic imaging, diabetes management, and emergency stroke care.

Differentiator

Problem solved

Functional benefit

Products and services

• Radiation-Free Diagnostic Imager A radiation-free diagnostic imaging device using Non-Linear Standing Wave Interferometry (NL-SWI) that uses harmless acoustic waves to achieve near-molecular precision. Designed to replace MRI, CT, and conventional ultrasound capabilities in a single portable device without radiation, magnets, helium, or dedicated infrastructure, and to enable continuous viewing over extended periods at zero risk.
• Non-Invasive Glucose Monitor A non-invasive blood glucose measurement device that measures glucose through closed eyelids using acoustic waves. The device sends acoustic waves into the eye's vitreous humor and measures transit time with approximately 10 picosecond resolution, providing direct blood glucose readings in less than ten seconds without needles or blood draw.
• Brain Stroke Detection Device An accurate brain ultrasound device using low-frequency acoustic waves (approximately 200 KHz) that penetrate the skull with sub-millimetre precision. Provides full brain and head imaging with multiple cross-sections, designed to work in ambulances, clinics, or at bedside to enable rapid stroke detection without CT or MRI.

Quantifiable outcome

• 2 million neurons saved per minute in stroke diagnosis
• +4 more outcomes

Segments5 records

Ideal customer profiles2 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature5 records

Partnerships

Two partnerships are on record, tiered historical and validation.

• Fortune 500 CompanieshistoricalStrategic or Co-development PartnerThe previous generation technology earned 26 patents and had working collaborations with Fortune 500 companies, demonstrating the strength of the underlying physics and commercial potential of the technology platform.
• NASA Langley Research CentervalidationTechnology or IntegrationIndependent validation of underlying physics. The same underlying physics — ultrasonic phase measurement at sub-micron resolution — has been independently demonstrated at NASA Langley Research Center (Haldren et al., Rev. Sci. Instrum. 89, 054902, 2018).

Scale indicators6 records

Recent moves5 records

Expansion highlights3 records

Direct peers

• Dexcom: Dexcom is the dominant continuous glucose monitor company, competing with Offner's non-invasive glucose monitor for the same diabetic patient population. Both target replacing painful finger-prick testing, though Dexcom's CGM is minimally invasive rather than fully non-invasive.
• Butterfly Network: Butterfly Network makes portable, handheld whole-body ultrasound devices that connect to a smartphone, directly competing with Offner's radiation-free portable imaging ambition. Both target point-of-care, infrastructure-light diagnostic imaging in settings where traditional ultrasound/MRI/CT are unavailable.
• Abbott (FreeStyle Libre): Abbott's FreeStyle Libre is the leading flash glucose monitoring system globally, directly competing with Offner's non-invasive glucose device for the same 537M+ diabetic patient market. Both aim to eliminate routine finger-prick blood glucose testing.
• Hyperfine: Hyperfine manufactures the Swoop portable MRI, the most direct peer in the portable, radiation-free brain imaging category Offner is targeting with its brain ultrasound for stroke detection. Both aim to bring brain imaging out of the radiology suite into ambulances, ERs, and bedside.

Broad incumbents

• Canon Medical Systems: Canon Medical Systems is a broad-line diagnostic imaging incumbent with MRI, CT, ultrasound, and X-ray portfolios. Serves the same hospitals and clinical imaging use cases as Offner's radiation-free imaging ambition.
• Siemens Healthineers: Siemens Healthineers is one of the largest diagnostic imaging incumbents globally with MRI, CT, ultrasound, and AI imaging software. Offner's radiation-free imager competes for the same hospital imaging budgets and clinical workflows that Siemens dominates.
• GE HealthCare: GE HealthCare is a dominant broad-line medical imaging incumbent (MRI, CT, ultrasound, X-ray) whose installed base and hospital relationships Offner's radiation-free imager would challenge. Same end-customer (radiology departments, hospitals) but GE's portfolio is far broader than Offner's single imaging modality.
• Philips Healthcare: Philips is a major incumbent in diagnostic imaging, patient monitoring, and acute care — overlapping with Offner's radiation-free imaging and continuous monitoring ambitions. Same hospitals, same clinical use cases, but broader portfolio.

Emerging players

• Viz.ai: Viz.ai uses AI to coordinate stroke workflow and triage across hospital networks, addressing the same "minutes matter" stroke diagnosis gap that Offner's portable brain ultrasound aims to close via point-of-care imaging rather than workflow software.
• RapidAI: RapidAI provides AI-based stroke imaging analysis software that interprets CT/CT-angiography perfusion scans to accelerate stroke triage. It is an emerging player addressing the same time-critical stroke diagnosis pain point that Offner's portable brain ultrasound targets, though via software on existing scanners rather than a new imaging modality.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat3 records

Key risks6 records

Key highlights6 records

Customer concentration

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Offner Technologies